← FDA DRUG APPROVALS

FDA BLA · BLA125399

ADCETRIS

Sponsor: SEATTLE GENETICS

APPLICATION
BLA125399
TYPE
BLA
ORIGINAL APPROVAL
2011-08-19
LATEST ACTION
2011-08-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ADCETRISPrescription
BRENTUXIMAB VEDOTIN 50MG/VIAL · INJECTABLE · INJECTION

Approval history

2011-08-19OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →